Drug Recalls

Here you'll find every drug recall the FDA has issued, including prescription medications, over-the-counter drugs, compounded pharmacy products, and dietary supplements. We've been tracking these since 2006 and our database updates several times a day so you're always looking at current information.

Drugs get recalled for a number of reasons: contamination during manufacturing, incorrect potency or dosage, failed quality testing (like dissolution or stability tests), sterility problems in injectable products, or labeling and packaging errors that could cause someone to take the wrong dose. If you find a product on this list that you use, please follow the instructions provided by the FDA to take the necessary precautions.

17,529 total recalls
0 this month

Showing 8361–8380 of 17,529 recalls

August 1, 2018· Baxter Healthcare Corporation

Recalled Item: Levofloxacin Injection in 5% Dextrose

The Issue: Superpotent Drug: High out of specification results for

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
August 1, 2018· Akorn, Inc.

Recalled Item: Lidocaine 2.5% and Prilocaine Cream

The Issue: Failed Impurities/Degredation Specifications: Out of Specification results for

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
August 1, 2018· Baxter Healthcare Corporation

Recalled Item: Levofloxacin Injection in 5% Dextrose

The Issue: Superpotent Drug: High out of specification results for

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
August 1, 2018· Baxter Healthcare Corporation

Recalled Item: Levofloxacin Injection in 5% Dextrose

The Issue: Superpotent Drug: High out of specification results for

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
July 30, 2018· NuCare Pharmaceuticals Inc

Recalled Item: Valsartan/HCTZ 320/25mg Tablets

The Issue: CGMP Deviations: Carcinogen impurity detected in API used

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
July 30, 2018· NuCare Pharmaceuticals Inc

Recalled Item: Valsartan/HCTZ 160/12.5 mg Tablets

The Issue: CGMP Deviations: Carcinogen impurity detected in API used

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
July 30, 2018· NuCare Pharmaceuticals Inc

Recalled Item: Valsartan/HCTZ 160/25mg Tablets

The Issue: CGMP Deviations: Carcinogen impurity detected in API used

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
July 30, 2018· MAJOR PHARMACEUTICALS

Recalled Item: Doxycycline Hyclate Tablets

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
July 27, 2018· Bryant Ranch Prepack Inc.

Recalled Item: Valsartan 80 mg tablets

The Issue: CGMP Deviations: Carcinogen impurity detected in API used

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
July 27, 2018· Bryant Ranch Prepack Inc.

Recalled Item: Valsartan 320 mg tablets

The Issue: CGMP Deviations: Carcinogen impurity detected in API used

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
July 27, 2018· Bryant Ranch Prepack Inc.

Recalled Item: Valsartan 320 mg tablets

The Issue: CGMP Deviations: Carcinogen impurity detected in API used

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
July 26, 2018· Lupin Pharmaceuticals Inc.

Recalled Item: Moxifloxacin Ophthalmic Solution USP

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
July 26, 2018· Right Value Drug Stores, Inc.

Recalled Item: Testosterone 200 mg Pellet

The Issue: Labeling: Incorrect or Missing Lot and/or Exp Date:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
July 26, 2018· H J Harkins Company Inc dba Pharma Pac

Recalled Item: Valsartan tablets 160 mg

The Issue: Carcinogen impurity detected in API used to manufacture

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
July 25, 2018· Ranier's Compounding Laboratory

Recalled Item: Morphine Sulf inhalation

The Issue: Lack of Assurance of Sterility: Practices at firm

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
July 25, 2018· Ranier's Compounding Laboratory

Recalled Item: Triple P (Prostaglandin/Papaverine/Phentolamine) Injection

The Issue: Lack of Assurance of Sterility: Practices at firm

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
July 25, 2018· Ranier's Compounding Laboratory

Recalled Item: P/P/P (Prostaglandin/Papaverine/Phentolamine) Injection

The Issue: Lack of Assurance of Sterility: Practices at firm

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
July 25, 2018· Ranier's Compounding Laboratory

Recalled Item: P/P/P 0.02/40/2mg/mL(Prostaglandin//Papaverine/Phentolamine) Injection

The Issue: Lack of Assurance of Sterility: Practices at firm

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
July 25, 2018· Ranier's Compounding Laboratory

Recalled Item: Avastin 1.25 mg/0.05 mL prefilled syringe

The Issue: Lack of Assurance of Sterility: Practices at firm

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
July 25, 2018· Ranier's Compounding Laboratory

Recalled Item: PRASH 12.2mcg/1.22m/19.29 (Prostaglandin/Phentolamine/Papaverine) Injection

The Issue: Lack of Assurance of Sterility: Practices at firm

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund